Giancarlo Silvio Marenzi
@ccfm.it
Cardiologico Monzino
Scopus Publications
- Percutaneous coronary intervention in nonagenarians with acute myocardial infarction: a 15-year population-based study
Giancarlo Marenzi, Nicola Cosentino, Daniela Mele, Filippo Trombara, Giampaolo D’Aleo, Paolo Poggio, Olivia Leoni, Stefano Savonitto, Claudia Lucci, Alice Bonomi, Piergiuseppe Agostoni
Scientific Reports, 2026
The use of percutaneous coronary intervention (PCI) in very elderly patients (> 90 years) with acute myocardial infarction (AMI) remains debated due to limited evidence and the presence of multimorbidity. This study evaluated the impact of PCI using data from the Lombardy Health Database (Italy) for AMI patients hospitalized between 2003 and 2018. Among 15,954 patients (median age 92; 71% female; 50% with ST-elevation myocardial infarction [STEMI]), 12% underwent PCI. In-hospital mortality was lower in PCI-treated patients (15% vs. 23%; P < 0.0001). Overall, one-year mortality (56%) and rehospitalization for acute heart failure (AHF) or AMI (19%) were also reduced among PCI patients (37% vs. 58% and 16% vs. 21%, respectively; P < 0.0001). These findings were consistent across both STEMI and non-ST-elevation myocardial infarction (NSTEMI) subgroups and were independent of comorbidities. Adjusted risk analyses and propensity score matching (1,950 patients per group) confirmed these benefits. The use of PCI increased significantly from 4% in 2003 to 22% in 2018, while in-hospital mortality declined from 22 to 19% (from 28 to 15% in the propensity-matched cohort). In conclusion, PCI was associated with significantly lower in-hospital and one-year mortality, as well as reduced rehospitalization rates, in AMI patients older than 90 years, regardless of comorbidities. - Severe obesity and in-hospital outcomes in acute myocardial infarction: Insights into the role of systemic inflammation
Nicola Cosentino, Letizia Velato, Alice Bonomi, Chiara Morocutti, Filippo Trombara, Stefano Genovese, Chiara Molinari, Claudia Lucci, Marco Grazi, Emilio Assanelli, Sabato Sorrentino, Gianluca Pontone, Giancarlo Marenzi
International Journal of Cardiology, 2026 - Prognostic Impact of Cancer in Patients Hospitalized for Acute Myocardial Infarction: A Population-Based Cohort Study
Nicola Cosentino, Filippo Trombara, Matteo Franchi, Daniela Cardinale, Alice Bonomi, Mattia Dall’Asta, Olivia Leoni, Riccardo Maragna, Francesco Cannata, Gianluca Pontone, Giancarlo Marenzi
Journal of Clinical Medicine, 2026
Background: Cancer is common among patients with acute myocardial infarction (AMI) and may influence management and outcomes. The prognostic impact of cancer status (active vs. past) and its anatomical site remains insufficiently defined. We evaluated the association between cancer and short- and long-term outcomes after AMI in a large population cohort. Methods: Using linked administrative databases from Lombardy, Italy, we identified adults with a first AMI hospitalization from 2014 to 2022 (N = 124,403). Patients were categorized by cancer history, cancer status (active vs. past), and cancer site. The primary endpoint was in-hospital mortality; secondary endpoints were 1-year all-cause mortality and 1-year rehospitalization for AMI or acute heart failure (AHF). Multivariable log-binomial, Cox, and Fine&Gray models were applied. Results: Overall, 18,463 (14.8%) had a history of cancer. They were older and had higher comorbidity burden. Cancer history was associated with higher in-hospital mortality (adjusted risk ratio [RR] 1.06, 95% CI 0.99–1.13) and one-year mortality (adjusted hazard ratio [HR] 1.46, 95% CI 1.40–1.52). Active cancer carried the greatest risk (in-hospital RR 1.07, 95% CI 1.00–1.15; 1-year HR 1.60, 95% CI 1.53–1.68), whereas past cancer showed no excess mortality. Site-specific analyses identified lung (one-year HR 2.69, 95% CI 2.15–3.37) and hematological cancers (one-year HR 2.19, 95% CI 1.88–2.56) as highest-risk. Elevated mortality with cancer was consistent in STEMI and NSTEMI. Competing-risk analyses showed a similar risk of rehospitalization among cancer and non-cancer patients. Conclusions: In a real-world, unselected AMI population, cancer worsens short- and long-term survival, especially when active and involving the lungs or the hematopoietic tissues. Incorporating cancer status into AMI risk stratification and strengthening cardio-oncology pathways in acute care are warranted to improve patient outcomes. - Weekly and seasonal patterns of acute myocardial infarction in patients with and without diabetes mellitus: A population-based study
Nicola Cosentino, Alice Bonomi, Stefano Genovese, Chiara Molinari, Olivia Leoni, Gianluca Pontone, Giancarlo Marenzi
Nutrition Metabolism and Cardiovascular Diseases, 2026 - Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis
Veronika A Myasoedova, Vincenza Valerio, Ilaria Massaiu, Francesca Bertolini, Valentina Rusconi, Giancarlo Marenzi, Paolo Poggio
Open Heart, 2026
Background Fibrocalcific aortic valve sclerosis (AVSc), the earliest manifestation of aortic stenosis (AS), is increasingly recognised as a marker of systemic vascular damage and adverse cardiovascular outcomes. While a subset of AVSc patients progresses to AS, reported rates vary widely. We conducted a systematic review and meta-analysis to better define the natural history of AVSc progression. Methods Following Preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, we searched PubMed, Scopus and Web of Science through July 2025 for observational studies reporting AS development in AVSc patients. Primary outcomes were progression to any degree of AS and to severe AS. Pooled event rates were calculated using a random-effects model. Heterogeneity and publication bias were assessed using standard statistical methods. Meta-regression explored associations with clinical and demographic variables. Results Eight studies (n=12 388 patients) reported on the progression of AVSc patients to any AS stage, and nine studies (n=19 486 patients) on the progression to severe AS. Over a median follow-up of 4.0 years, 14.1% of AVSc patients progressed to any AS stage (effect size: 0.14; 95% CI 0.02 to 0.53), and 2.0% to severe AS (effect size: 0.02; 95% CI 0.003 to 0.094). Heterogeneity was high, but no publication bias was detected. Meta-regression found no significant predictors of progression. Conclusions Approximately one in six AVSc patients progresses to AS within 4 years, and 2% develop a severe disease. These findings underscore the importance of structured echocardiographic surveillance and support AVSc as a clinically relevant marker of systemic cardiovascular risk. - Hypoglycemia and glycemic variability in acute myocardial infarction: the lesser-known aspects of glycemic control
Claudia Lucci, Alessandro Marongiu, Stefano Genovese, Mario Mazza, Nicola Cosentino, Giancarlo Marenzi
Cardiovascular Diabetology, 2025
Glucose abnormalities are common in patients with acute myocardial infarction (AMI) and significantly influence prognosis. While acute hyperglycemia on admission has long been recognized as a predictor of adverse outcomes, growing evidence suggests that hypoglycemia and glycemic variability (GV) are equally, if not more, prognostically relevant. These glycemic excursions, whether spontaneous or iatrogenic, are associated with increased risks of mortality, reinfarction, heart failure, and arrhythmias. The underlying mechanisms include sympathetic overactivation, endothelial dysfunction, inflammation, oxidative stress, thrombogenesis, and electrophysiological instability. Despite their clinical significance, hypoglycemia and GV remain insufficiently addressed in current AMI management protocols. Glycemic variability is often assessed through heterogeneous metrics-such as standard deviation, coefficient of variation, and mean amplitude of glycemic excursions, limiting comparability across studies. Additionally, reliance on intermittent glucose monitoring hinders accurate detection of hypoglycemic episodes, particularly those that are asymptomatic or nocturnal. The interaction between acute glycemic fluctuations and myocardial ischemia is also poorly understood, and the efficacy of interventions specifically targeting these disturbances remains to be established. Moreover, while observational studies have linked both hypoglycemia and GV with poor outcomes in AMI, interventional trials specifically targeting these abnormalities are lacking. This review aims to synthesize current evidence on the clinical and prognostic significance of hypoglycemia and GV in patients with AMI, offering an integrative overview of their prevalence, underlying mechanisms, and impact on outcomes, while highlighting key knowledge gaps and directions for future research. - Non-stenotic fibro-calcific aortic valve as a predictor of myocardial infarction recurrence
Veronika A Myasoedova, Mattia Chiesa, Nicola Cosentino, Alice Bonomi, Monica Ludergnani, Michele Bozzi, Vincenza Valerio, Donato Moschetta, Ilaria Massaiu, Valentina Mantegazza, Giancarlo Marenzi, Paolo Poggio
European Journal of Preventive Cardiology, 2025
Aims Patients with acute myocardial infarction (AMI) are at increased risk of recurrent cardiovascular events. Non-stenotic aortic valve fibro-calcific remodelling (called aortic valve sclerosis; AVSc), reflecting systemic damage, may serve as a new marker of risk. This study aims to stratify subgroups of AMI patients with specific probabilities of recurrent AMI and to evaluate the importance of AVSc in this setting. Methods and results Consecutive AMI patients (n = 2530) were admitted at Centro Cardiologico Monzino (2010–19) and followed up for 5 years. Patients were divided into study (n = 1070) and test (n = 966) cohorts. Topological data analysis (TDA) was used to stratify patient subgroups, while Kaplan–Meier and Cox regression analyses were used to evaluate the significance of baseline characteristics. Topological data analysis identified 11 subgroups of AMI patients with specific baseline characteristics. Two subgroups showed the highest rate of re-infarction after 5 years from the indexed AMI with a combined hazard ratio (HR) of 3.8 [95% confidence interval (CI): 2.7–5.4] compared with the other subgroups. This was confirmed in the test cohort (HR = 3.1; 95% CI: 2.2–4.3). These two subgroups were mostly men, with hypertension and dyslipidaemia, who exhibit a higher prevalence of AVSc, higher levels of high-sensitive C-reactive protein and creatinine. In the year-by-year analysis, AVSc, adjusted for all confounders, showed an independent association with the increased risk of re-infarction (odds ratio of ∼2 at all time points), in both the study and the test cohorts (all P &lt; 0.01). Conclusion AVSc is a crucial variable for identifying AMI patients at high risk of recurrent AMI and its presence should be considered when assessing the management of AMI patients. The inclusion of AVSc in risk stratification models may improve the accuracy of predicting the likelihood of recurrent AMI, leading to more personalized treatment decisions. - Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: The MECKI-RENAL study
Massimo Mapelli, Elisabetta Salvioni, Nicola Cosentino, Francesca Pluchinotta, Arianna Galotta, Alice Bonomi, Michele Emdin, Massimo Piepoli, Gianfranco Sinagra, Michele Senni, Jeness Campodonico, Anna Apostolo, Alessandro Nava, Damiano Magrì, Stefania Paolillo, Ugo Corrà, Rosa Raimondo, Antonio Cittadini, Annamaria Iorio, Andrea Salzano, Rocco Lagioia, Carlo Vignati, Roberto Badagliacca, Pasquale Perrone Filardi, Mauro Contini, Michele Correale, Enrico Perna, Marco Metra, Beatrice Pezzuto, Maddalena Rossi, Pietro Palermo, Gaia Cattadori, Marco Guazzi, Giuseppe Limongelli, Gianfranco Parati, Nicola Campana, Maria Vittoria Matassini, Francesco Bandera, Maurizio Bussotti, Federica Re, Carlo M Lombardi, Angela B Scardovi, Stefania Farina, Giulia Grilli, Susanna Sciomer, Andrea Passantino, Caterina Santolamazza, Davide Girola, Claudio Passino, Irene Mattavelli, Marco Scatigna, Arianna Piotti, Federica Mescia, Giancarlo Marenzi, Piergiuseppe Agostoni
European Heart Journal Quality of Care and Clinical Outcomes, 2025
Aims Appropriate interpretation of kidney function is essential for clinical and therapeutic management of heart failure (HF). We evaluated the prognostic accuracy of 6 glomerular filtration rate estimation (eGFR) formulas in HF patients with reduced ejection fraction (HFrEF) and their impact on the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score prognostic accuracy. Methods and results We retrospectively analyzed 6933 patients enrolled in the MECKI score database. GFR was estimated using Modification of Diet in Renal Disease (MDRD); MRDR modified (MDRDm); Cockcroft-Gault (CG), CG modified (CGm); Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and the European Kidney Function Consortium (EKFC). Survival was assessed as the composite of cardiovascular death, left ventricular assist device implantation and urgent heart transplantation at 2 years. Each GFR estimation demonstrated similar but moderate prognostic capacity, with the area under the curve (AUC) for predicting survival ranging from 0.6271 (EKFC) to 0.635 (MDRD). For cardiovascular death, the AUC values ranged from 0.668 to 0.677. The prevalence of severe CKD, defined as eGFR &lt;30 mL/min/1.73 m², ranged from 3.2% (MDRD) to 4.5% (EKFC). When included in MECKI score, the 6 formulas showed a MECKI AUC for prognosis ranging from 0.7841 to 0.7883, with the EKFC and CKD-EPI showing the best performance. Conclusion GFR estimations play a role in HFrEF prognosis without difference among the 6 most frequently used formulas. Furthermore, using eGFR calculated from the 6 different formulas in MECKI score did not significantly alter its strong prognostic power, highlighting MECKI reliability in risk stratification. - Exploring sex differences in mortality among acute myocardial infarction
Lorenzo Cangiano, Alice Bonomi, Nicola Cosentino, Olivia Leoni, Filippo Trombara, Veronika A Myasoedova, Paolo Poggio, Daniela Trabattoni, Piergiuseppe Agostoni, Giancarlo Marenzi
Open Heart, 2025
Background Women with acute myocardial infarction (AMI) experience higher mortality rates than men. This disparity is influenced by factors such as older age, greater comorbidity burden, atypical symptom presentation and delays in treatment. This study analysed patients with AMI (2003–2018) from the Lombardy Health Database (Italy) to examine sex differences in in-hospital and 1-year mortality and the role of age, percutaneous coronary intervention (PCI) and postdischarge therapy. Methods and results Among 263 564 patients with AMI (93 363 women, 170 201 men), primary and secondary endpoints were in-hospital and 1-year mortality, respectively. Path analysis evaluated the direct and indirect effects of sex on outcomes, incorporating age, PCI and postdischarge therapy as mediators. Women had higher in-hospital (10% vs 5%; p<0.0001) and 1-year mortality (24% vs 14%; p<0.0001) but were less likely to receive PCI (40% vs 61%; p<0.0001) and postdischarge therapy (dual antiplatelet therapy 53% vs 63%; ACE inhibitors/angiotensin receptor blockers 60% vs 64%; beta blockers 53% vs 61%; lipid-lowering drugs 45% vs 58%; p<0.0001 for all differences). After adjusting for age, major comorbidities, PCI and postdischarge treatment, mortality differences were no longer significant (adjusted OR 1.04; 95% CI 0.99 to 1.07 for in-hospital mortality) or even reversed (adjusted HR 0.94; 95% CI 0.92 to 0.96 for 1-year mortality). Path analysis showed that female sex directly contributed 12% to in-hospital mortality and 4% to 1-year mortality, while age and undertreatment accounted for most of the disparity (88% and 96%, respectively). Conclusion Women with AMI face higher mortality largely due to older age and undertreatment during hospitalisation and after discharge. Addressing these gaps could improve outcomes. - Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists
Nicola Cosentino, Filippo Trombara, Monica De Metrio, Chiara Molinari, Stefano Genovese, Gianluca Pontone, Giancarlo Marenzi
Pharmaceuticals, 2025
Coronary artery disease (CAD) and its acute manifestation, myocardial infarction (AMI), remain significant global health burdens, with a substantial impact on morbidity and mortality, especially in individuals with Type 2 Diabetes Mellitus (T2DM). The interaction between hyperglycemia, endothelial dysfunction, inflammation, and thrombosis creates a complex pathological environment that contributes to the progression of CAD and its acute complications, including AMI. Over recent years, there has been a shift in the therapeutic approach to CAD, especially in T2DM patients, where pharmacologic agents originally developed for glycemic control have demonstrated notable cardiovascular benefits beyond glucose regulation. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are at the forefront of this paradigm shift. Initially, these agents were designed to improve glycemic control, but their broader cardiovascular protective effects have become increasingly evident, particularly in patients with CAD. This review aims to provide an in-depth exploration of the mechanistic underpinnings of these agents, the clinical data supporting their cardiovascular benefits, and their potential role for patients with CAD. - Furosemide-hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline
Massimo Mapelli, Filippo Maria Rubbo, Jeness Campodonico, Nicola Cosentino, Giancarlo Marenzi, Valentina Mantegazza, Filippo Trombara, Mateusz Sokolski, Piotr Ponikowski, Piergiuseppe Agostoni
Esc Heart Failure, 2025 - Atrial Fibrillation Is Associated With Increased In-Hospital and 1-Year Mortality in Patients Receiving Hemodialysis With ST Elevation Myocardial Infarction: A Retrospective Cohort Study
Simonetta Genovesi, Giuseppe Regolisti, Alice Bonomi, Olivia Leoni, Arianna Galotta, Giancarlo Marenzi
Kidney Medicine, 2025 - Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients
Daniela Cardinale, Giancarlo Marenzi
Jacc Cardiooncology, 2025 - MINOCA and Type 2 mycardial infarction: Unveiling the hidden differences
Lorenzo Cangiano, Nicola Cosentino, Giancarlo Marenzi
International Journal of Cardiology, 2025 - Characteristics and outcomes of patients with cancer hospitalized with new onset acute heart failure
Giancarlo Marenzi, Daniela Cardinale, Nicola Cosentino, Filippo Trombara, Paolo Poggio, Olivia Leoni, Francesco Bortolan, Marta Resta, Claudia Lucci, Nicolò Capra, Alice Bonomi, Piergiuseppe Agostoni
Esc Heart Failure, 2025 - Temporal trends (2003–2018) of in-hospital and 30-day mortality in patients hospitalized with acute heart failure
Giancarlo Marenzi, Nicola Cosentino, Livio Imparato, Filippo Trombara, Olivia Leoni, Francesco Bortolan, Matteo Franchi, Erica Rurali, Paolo Poggio, Jeness Campodonico, Fabrizio Oliva, Alice Bonomi, Piergiuseppe Agostoni
International Journal of Cardiology, 2025 - Tissue Factor, a Membrane-associated Marker of Platelet Activation, Predicts 5-year Cardiovascular Mortality in Coronary Artery Disease Patients
Marina Camera, Marta Brambilla, Nicola Cosentino, Alessia Becchetti, Patrizia Della Valle, Daniela Trabattoni, Mattia Galli, Arianna Galotta, Veronika Myasoedova, Alice Bonomi, Federica Fumoso, Francesca Besson, Giancarlo Marenzi, Paolo Poggio, Maria Conti, Kevin Nallio, Fabrizio Veglia, Elena Tremoli
Thrombosis and Haemostasis, 2025 - Deceived by the Fick principle: blood flow distribution in heart failure
Piergiuseppe Agostoni, Gaia Cattadori, Carlo Vignati, Anna Apostolo, Stefania Farina, Elisabetta Salvioni, Silvia Di Marco, Andrea Sonaglioni, Savina Nodari, Giancarlo Marenzi, Arno Schmidt-Trucksäss, Jonathan Myers
European Journal of Preventive Cardiology, 2024 - The network of the EASY-NET programme: a contribution to knowledge on the effectiveness of audit&feedback
A. Acampora, L. Angelici, L. Deroma, Annarita Tullio, G. Ciccone, E. Pagano, Giulio Marchesini, G. Marenzi, Alice Bonomi, Roberta Venturella, F. Zambri, J. Preziosi, Angela Giusti, Alice Maraschini, A. Mignuoli, P. Bramanti, Rossella Ciurleo, M. Davoli, N. Agabiti
Epidemiologia E Prevenzione, 2024 - Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial
Felice Achilli, Stefano Maggiolini, Fabiana Madotto, Beatrice Bassetti, Francesco Gentile, Aldo Pietro Maggioni, Gualtiero I Colombo, Giulio Pompilio
Heart, 2024 - Whole-Blood Transcriptome Unveils Altered Immune Response in Acute Myocardial Infarction Patients with Aortic Valve Sclerosis
Luca Piacentini, Veronika A. Myasoedova, Mattia Chiesa, Chiara Vavassori, Donato Moschetta, Vincenza Valerio, Gloria Giovanetti, Ilaria Massaiu, Nicola Cosentino, Giancarlo Marenzi, Paolo Poggio, Gualtiero I. Colombo
Arteriosclerosis Thrombosis and Vascular Biology, 2024 - Vitamin D and cardiovascular diseases
Valentina Milazzo, Nicola Cosentino, Filippo Trombara, Giancarlo Marenzi
Advances in Food and Nutrition Research, 2024 - Prediction of In-Hospital Atrial Fibrillation After Acute Myocardial Infarction
Matteo Bulloni, Guadalupe García Isla, Pedro Moreno-Sánchez, Erica Rurali, Alice Bonesi, Mattia Chiesa, Pablo Werba, Giancarlo Marenzi, Valentina Corino, Claudio Tondo, Mark van Gils, Linda Pattini, Luca Mainardi
Computing in Cardiology, 2024 - Unstable angina: A clinical entity on the verge of extinction?
Claudia Lucci, Nicola Cosentino, Giancarlo Marenzi
International Journal of Cardiology, 2023 - Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
Filippo Trombara, Nicola Cosentino, Alice Bonomi, Monica Ludergnani, Paolo Poggio, Luigia Gionti, Marta Baviera, Pierluca Colacioppo, Maria Carla Roncaglioni, Olivia Leoni, Francesco Bortolan, Piergiuseppe Agostoni, Stefano Genovese, Giancarlo Marenzi
Cardiovascular Diabetology, 2023 - Intracranial haemorrhage in acute myocardial infarction: A rare but dramatic complication
Filippo Trombara, Nicola Cosentino, Giancarlo Marenzi
International Journal of Cardiology, 2023 - How to optimize Audit&Feedback: experience from the EASY-NET programme
Anna Acampora, Carmen Angioletti, Melissa D’Agostino, Laura Deroma, Annarita Tullio, et al.
Epidemiologia E Prevenzione, 2023 - Glomerular filtration rate estimation and all-cause and cardiovascular mortality risk prediction: a progressive refinement in accuracy
Nicola Cosentino, Filippo Trombara, Giancarlo Marenzi
European Journal of Preventive Cardiology, 2023 - Fluid balance in heart failure
Nicola Cosentino, Giancarlo Marenzi, Manuela Muratori, Damiano Magrì, Gaia Cattadori, Piergiuseppe Agostoni
European Journal of Preventive Cardiology, 2023 - Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12and Link to Residual Platelet Reactivity
Marta Brambilla, Alessia Becchetti, Gian Enrico Rovati, Nicola Cosentino, Maria Conti, Paola Canzano, Peter L.A. Giesen, Alessia Loffreda, Alice Bonomi, Marco Cattaneo, Erica De Candia, Gian Marco Podda, Daniela Trabattoni, Pablo Josè Werba, Jeness Campodonico, Christian Pinna, Giancarlo Marenzi, Elena Tremoli, Marina Camera
Arteriosclerosis Thrombosis and Vascular Biology, 2023 - Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients
Marta Zarà, Andrea Baggiano, Patrizia Amadio, Jeness Campodonico, Sebastiano Gili, Andrea Annoni, Gianluca De Dona, Maria Ludovica Carerj, Francesco Cilia, Alberto Formenti, Laura Fusini, Cristina Banfi, Paola Gripari, Calogero Claudio Tedesco, Maria Elisabetta Mancini, Mattia Chiesa, Riccardo Maragna, Francesca Marchetti, Marco Penso, Luigi Tassetti, Alessandra Volpe, Alice Bonomi, Giancarlo Marenzi, Gianluca Pontone, Silvia Stella Barbieri
Biomolecules, 2023 - Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database
Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan, Stefano Savonitto, Piergiuseppe Agostoni
Journal of Clinical Medicine, 2023 - Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: Findings from the Lombardy Health Database
Nicola Cosentino, Simonetta Genovesi, Alice Bonomi, Filippo Trombara, Monica Ludergnani, Olivia Leoni, Francesco Bortolan, Piergiuseppe Agostoni, Giancarlo Marenzi
Reviews in Cardiovascular Medicine, 2023 - Reply to: The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
Nicola Cosentino, Giancarlo Marenzi, Mattia Chiesa
Journal of General Internal Medicine, 2023 - The EASY-NET research programme: background, structure, and methodology
A. Acampora, Laura Deroma, Giovannino Ciccone, Giulio Marchesini Reggiani, Giancarlo Marenzi, Roberta Venturella, Placido Bramanti, Roberto Grilli, Mirko Di Martino, Teresa Spadea, Luca De Fiore, Nera Agabiti
Epidemiologia E Prevenzione, 2023 - Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction
Marta Baviera, Stefano Genovese, Pierluca Colacioppo, Nicola Cosentino, Andreana Foresta, Mauro Tettamanti, Ida Fortino, Maria Carla Roncaglioni, Giancarlo Marenzi
Cardiovascular Diabetology, 2022 - Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial
Rocco Antonio Montone, Nicola Cosentino, Francesca Graziani, Riccardo Gorla, Marco Giuseppe Del Buono, Giulia La Vecchia, Riccardo Rinaldi, Giancarlo Marenzi, Antonio L. Bartorelli, Federico De Marco, Luca Testa, Francesco Bedogni, Carlo Trani, Giovanna Liuzzo, Giampaolo Niccoli, Filippo Crea
Eurointervention, 2022 - Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus
C. Di Mario, S. Genovese, G. Lanza, E. Mannucci, G. Marenzi, E. Sciatti, D. Pitocco, Angelo Federico Enzo Claudio Raffaella Stefano Davide Ago Avogaro Bertuzzi Bonora Borghi Buzzetti Carugo Cap, A. Avogaro, F. Bertuzzi, E. Bonora, C. Borghi, R. Buzzetti, S. Carugo, D. Capodanno, A. Consoli, A. Conti, R. Danesi, P. Bartolo, G. Ferrari, S. Favale, C. Giorda, F. Giorgino, A. Girelli, P. Golino, F. Grigioni, C. Indolfi, C. Irace, E. Lovati, A. Maffettone, M. Masulli, F. Oliva, L. Oltrona Visconti, E. Orsi, U. Pagotto, L. Paloscia, G. Parati, Pasquale Perrone, G. Piccirillo, P. Pozzilli, G. Pugliese, F. Purrello, F. Ribichini, A. Rubboli, M. Senni, R. Trevisan, C. Tubili, M. Uguccioni
Cardiovascular Diabetology, 2022 - Outcomes and mechanical complications of acute myocardial infarction during the second wave pandemic in a Milan HUB center for cardiac emergencies
Marco Penso, Antonio Frappampina, Nicola Cosentino, Gloria Tamborini, Fabrizio Celeste, Monica Ianniruberto, Paolo Ravagnani, Sarah Troiano, Giancarlo Marenzi, Mauro Pepi
Frontiers in Cardiovascular Medicine, 2022 - Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
Nicola Cosentino, Claudia Lucci, Giancarlo Marenzi
International Journal of Cardiology, 2022 - Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention
Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba, Alice Bonomi, Giancarlo Marenzi
Journal of Clinical Medicine, 2022 - The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
Nicola Cosentino, Giancarlo Marenzi, Mattia Chiesa
Journal of General Internal Medicine, 2022 - Acute Coronary Syndromes and SARS-CoV-2 Infection: Results From an Observational Multicenter Registry During the Second Pandemic Spread in Lombardy
Marco Ferlini, Diego Castini, Giulia Ferrante, Giancarlo Marenzi, Matteo Montorfano, Stefano Savonitto, Maurizio D’Urbano, Corrado Lettieri, Claudio Cuccia, Marcello Marino, Luigi Oltrona Visconti, Stefano Carugo
Frontiers in Cardiovascular Medicine, 2022 - European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis
, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio L Bartorelli, Andreas Baumbach, Elijah R Behr, Sergio Berti, Héctor Bueno, Davide Capodanno, Riccardo Cappato, Alaide Chieffo, Jean-Philippe Collet, Thomas Cuisset, Giovanni de Simone, Victoria Delgado, Paul Dendale, Dariusz Dudek, Thor Edvardsen, Arif Elvan, José R González-Juanatey, Mauro Gori, Diederick Grobbee, Tomasz J Guzik, Sigrun Halvorsen, Michael Haude, Hein Heidbuchel, Gerhard Hindricks, Borja Ibanez, Nicole Karam, Hugo Katus, Fredrikus A Klok, Stavros V Konstantinides, Ulf Landmesser, Christophe Leclercq, Sergio Leonardi, Maddalena Lettino, Giancarlo Marenzi, Josepa Mauri, Marco Metra, Nuccia Morici, Christian Mueller, Anna Sonia Petronio, Marija M Polovina, Tatjana Potpara, Fabien Praz, Bernard Prendergast, Eva Prescott, Susanna Price, Piotr Pruszczyk, Oriol Rodríguez-Leor, Marco Roffi, Rafael Romaguera, Stephan Rosenkranz, Andrea Sarkozy, Martijn Scherrenberg, Petar Seferovic, Michele Senni, Francesco R Spera, Giulio Stefanini, Holger Thiele, Daniela Tomasoni, Luccia Torracca, Rhian M Touyz, Arthur A Wilde, Bryan Williams
Cardiovascular Research, 2022 - ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 2-care pathways, treatment, and follow-up
The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, et al.
Cardiovascular Research, 2022 - ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio L Bartorelli, Andreas Baumbach, Elijah R Behr, Sergio Berti, Héctor Bueno, Davide Capodanno, Riccardo Cappato, Alaide Chieffo, Jean-Philippe Collet, Thomas Cuisset, Giovanni de Simone, Victoria Delgado, Paul Dendale, Dariusz Dudek, Thor Edvardsen, Arif Elvan, José R González-Juanatey, Mauro Gori, Diederick Grobbee, Tomasz J Guzik, Sigrun Halvorsen, Michael Haude, Hein Heidbuchel, Gerhard Hindricks, Borja Ibanez, Nicole Karam, Hugo Katus, Fredrikus A Klok, Stavros V Konstantinides, Ulf Landmesser, Christophe Leclercq, Sergio Leonardi, Maddalena Lettino, Giancarlo Marenzi, Josepa Mauri, Marco Metra, Nuccia Morici, Christian Mueller, Anna Sonia Petronio, Marija M Polovina, Tatjana Potpara, Fabien Praz, Bernard Prendergast, Eva Prescott, Susanna Price, Piotr Pruszczyk, Oriol Rodríguez-Leor, Marco Roffi, Rafael Romaguera, Stephan Rosenkranz, Andrea Sarkozy, Martijn Scherrenberg, Petar Seferovic, Michele Senni, Francesco R Spera, Giulio Stefanini, Holger Thiele, Daniela Tomasoni, Lucia Torracca, Rhian M Touyz, Arthur A Wilde, Bryan Williams
European Heart Journal, 2022 - European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio L Bartorelli, Andreas Baumbach, Elijah R Behr, Sergio Berti, Héctor Bueno, Davide Capodanno, Riccardo Cappato, Alaide Chieffo, Jean-Philippe Collet, Thomas Cuisset, Giovanni de Simone, Victoria Delgado, Paul Dendale, Dariusz Dudek, Thor Edvardsen, Arif Elvan, José R González-Juanatey, Mauro Gori, Diederick Grobbee, Tomasz J Guzik, Sigrun Halvorsen, Michael Haude, Hein Heidbuchel, Gerhard Hindricks, Borja Ibanez, Nicole Karam, Hugo Katus, Fredrikus A Klok, Stavros V Konstantinides, Ulf Landmesser, Christophe Leclercq, Sergio Leonardi, Maddalena Lettino, Giancarlo Marenzi, Josepa Mauri, Marco Metra, Nuccia Morici, Christian Mueller, Anna Sonia Petronio, Marija M Polovina, Tatjana Potpara, Fabien Praz, Bernard Prendergast, Eva Prescott, Susanna Price, Piotr Pruszczyk, Oriol Rodríguez-Leor, Marco Roffi, Rafael Romaguera, Stephan Rosenkranz, Andrea Sarkozy, Martijn Scherrenberg, Petar Seferovic, Michele Senni, Francesco R Spera, Giulio Stefanini, Holger Thiele, Daniela Tomasoni, Luccia Torracca, Rhian M Touyz, Arthur A Wilde, Bryan Williams
European Heart Journal, 2022 - Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups
Nicola Cosentino, Marta L. Resta, Alberto Somaschini, Jeness Campodonico, Claudia Lucci, Marco Moltrasio, Alice Bonomi, Stefano Cornara, Rita Camporotondo, Andrea Demarchi, Gaetano M. De Ferrari, Antonio L. Bartorelli, Giancarlo Marenzi
International Journal of Cardiology, 2021 - Vitamin d and cardiovascular disease: Current evidence and future perspectives
Nicola Cosentino, Jeness Campodonico, Valentina Milazzo, Monica De Metrio, Marta Brambilla, Marina Camera, Giancarlo Marenzi
Nutrients, 2021 - The role of glycemic variability in cardiovascular disorders
Valentina Alfieri, Veronika A. Myasoedova, Maria Cristina Vinci, Maurizio Rondinelli, Paola Songia, Ilaria Massaiu, Nicola Cosentino, Donato Moschetta, Vincenza Valerio, Michele Ciccarelli, Giancarlo Marenzi, Stefano Genovese, Paolo Poggio
International Journal of Molecular Sciences, 2021 - The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
Ganesh Raghu, Michael Berk, Peter A. Campochiaro, Hartmut Jaeschke, Giancarlo Marenzi, Luca Richeldi, Fu-Qiang Wen, Ferdinando Nicoletti, Peter M. A. Calverley
Current Neuropharmacology, 2021 - A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention
Stefano Buratti, Gabriele Crimi, Alberto Somaschini, Stefano Cornara, Rita Camporotondo, Nicola Cosentino, Marco Moltrasio, Mara Rubino, Monica De Metrio, Ivana Marana, Stefano De Servi, Giancarlo Marenzi, Gaetano M. De Ferrari
Catheterization and Cardiovascular Interventions, 2021 - Plasma exosome profile in st-elevation myocardial infarction patients with and without out-of-hospital cardiac arrest
Marta Zarà, Jeness Campodonico, Nicola Cosentino, Maria Luisa Biondi, Patrizia Amadio, Gloria Milanesi, Emilio Assanelli, Silvia Cerri, Marco Biggiogera, Leonardo Sandrini, Calogero Claudio Tedesco, Fabrizio Veglia, Daniela Trabattoni, Fabio Blandini, Elena Tremoli, Giancarlo Marenzi, Silvia S. Barbieri
International Journal of Molecular Sciences, 2021 - Veno-arterial extracorporeal membrane oxygenation in the adult: A bridge to the state of the art
Marco Gennari, Camilla L’Acqua, Mara Rubino, Marco Agrifoglio, Luca Salvi, Roberto Ceriani, Giancarlo Marenzi, Ivana Marana, Gianluca Polvani
Current Cardiology Reviews, 2021 - St‐segment elevation acute myocardial infarction complicated by cardiogenic shock: Early predictors of very long‐term mortality
Nicola Cosentino, Marta L. Resta, Alberto Somaschini, Jeness Campodonico, Giampaolo D’Aleo, Giovanni Di Stefano, Claudia Lucci, Marco Moltrasio, Alice Bonomi, Stefano Cornara, Andrea Demarchi, Gaetano De Ferrari, Antonio L. Bartorelli, Giancarlo Marenzi
Journal of Clinical Medicine, 2021 - Potential relation between plasma bdnf levels and human coronary plaque morphology
Patrizia Amadio, Nicola Cosentino, Sonia Eligini, Simone Barbieri, Calogero Claudio Tedesco, Leonardo Sandrini, Marta Zarà, Franco Fabiocchi, Giampaolo Niccoli, Giulia Magnani, Francesco Fracassi, Filippo Crea, Fabrizio Veglia, Giancarlo Marenzi, Silvia Stella Barbieri
Diagnostics, 2021 - Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis
Nicola Cosentino, Alice Bonomi, Jeness Campodonico, Fabrizio Veglia, Gaetano M. De Ferrari, Stefano Genovese, Giancarlo Marenzi
Nutrition Metabolism and Cardiovascular Diseases, 2021 - Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migration
Susanna Fiorelli, Andrea Anesi, Benedetta Porro, Nicola Cosentino, José P. Werba, Alessandro Di Minno, Chiara Maria Manega, Simone Barbieri, Gualtiero I. Colombo, Giancarlo Marenzi, Viviana Cavalca, Elena Tremoli, Sonia Eligini
FASEB Journal, 2021 - Ischaemic and bleeding risk in cancer patients undergoing PCI: Another brick in the wall
Giancarlo Marenzi, Nicola Cosentino, Daniela Cardinale
European Heart Journal, 2021 - Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation
Francesco Fracassi, Giampaolo Niccoli, Nicola Cosentino, Sonia Eligini, Susanna Fiorelli, Franco Fabbiocchi, Vincenzo Vetrugno, Hesham Refaat, Rocco Antonio Montone, Giancarlo Marenzi, Elena Tremoli, Filippo Crea
International Journal of Cardiology, 2021 - Netrin-1 in atherosclerosis: Relationship between human macrophage intracellular levels and in vivo plaque morphology
Susanna Fiorelli, Nicola Cosentino, Benedetta Porro, Franco Fabbiocchi, Giampaolo Niccoli, Francesco Fracassi, Nicolò Capra, Simone Barbieri, Filippo Crea, Giancarlo Marenzi, Viviana Cavalca, Elena Tremoli, Sonia Eligini
Biomedicines, 2021 - Mitochondrial biomarkers in patients with ST-elevation myocardial infarction and their potential prognostic implications: A prospective observational study
Nicola Cosentino, Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana, Marco Grazi, Alice Bonomi, Fabrizio Veglia, Gianfranco Lauri, Antonio L. Bartorelli, Giancarlo Marenzi
Journal of Clinical Medicine, 2021 - Acute Myocardial Infarction During the COVID-19 Pandemic: An Update on Clinical Characteristics and Outcomes
Olga Toscano, Nicola Cosentino, Jeness Campodonico, Antonio L. Bartorelli, Giancarlo Marenzi
Frontiers in Cardiovascular Medicine, 2021 - Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
Valentina Milazzo, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Mario Mazza, Monica De Metrio, Giancarlo Marenzi
Advances in Experimental Medicine and Biology, 2021 - Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients
Veronika A. Myasoedova, Stefano Genovese, Laura Cavallotti, Alice Bonomi, Mattia Chiesa, Jeness Campodonico, Maurizio Rondinelli, Nicola Cosentino, Damiano Baldassarre, Fabrizio Veglia, Mauro Pepi, Francesco Alamanni, Gualtiero I. Colombo, Giancarlo Marenzi, Paolo Poggio
Frontiers in Cardiovascular Medicine, 2021 - Whole blood transcriptome profile at hospital admission discriminates between patients with ST-segment elevation and non-ST-segment elevation acute myocardial infarction
Mattia Chiesa, Luca Piacentini, Elisa Bono, Valentina Milazzo, Jeness Campodonico, Giancarlo Marenzi, Gualtiero I. Colombo
Scientific Reports, 2020 - Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus
Claudia Lucci, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Valentina Milazzo, Monica De Metrio, Maurizio Rondinelli, Daniela Riggio, Maria Luisa Biondi, Mara Rubino, Katia Celentano, Alice Bonomi, Nicolò Capra, Fabrizio Veglia, Piergiuseppe Agostoni, Antonio L. Bartorelli, Giancarlo Marenzi
Cardiovascular Diabetology, 2020 - Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The “macro-hub” experience
Stefano Carugo, Marco Ferlini, Diego Castini, Aida Andreassi, Giulio Guagliumi, Marco Metra, Carlo Lombardi, Claudio Cuccia, Stefano Savonitto, Luigi Piatti, Maurizio D'Urbano, Corrado Lettieri, Pietro Vandoni, Maddalena Lettino, Giancarlo Marenzi, Matteo Montorfano, Alberto Zangrillo, Battistina Castiglioni, Roberto De Ponti, Luigi Oltrona Visconti
Ijc Heart and Vasculature, 2020 - Time to treatment still matters in ST-elevation myocardial infarction: A call to maintain treatment effectiveness during the COVID-19 pandemic
Nicola Cosentino, Antonio L Bartorelli, Giancarlo Marenzi
European Heart Journal Cardiovascular Pharmacotherapy, 2020 - Characteristics, management, and outcomes of acute coronary syndrome patients with cancer
Valentina Milazzo, Nicola Cosentino, Jeness Campodonico, Claudia Lucci, Daniela Cardinale, Carlo M. Cipolla, Giancarlo Marenzi
Journal of Clinical Medicine, 2020 - Rationale, experimental data, and emerging clinical evidence on early and preventive use of levosimendan in patients with ventricular dysfunction
Nicola Cosentino, Giampaolo Niccoli, Francesco Fracassi, Antonio Rebuzzi, Piergiuseppe Agostoni, Giancarlo Marenzi
European Heart Journal Cardiovascular Pharmacotherapy, 2020 - Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak
Marco Ferlini, Aida Andreassi, Stefano Carugo, Claudio Cuccia, Beatrice Bianchini, Battistina Castiglioni, Maurizio D' Urbano, Giulio Guagliumi, Corrado Lettieri, Maddalena Lettino, Giancarlo Marenzi, Marco Metra, Maurizio Migliori, Matteo Montorfano, Fabrizio Oliva, Stefano Savonitto, Romano Seregni, Luigi Oltrona Visconti
International Journal of Cardiology, 2020 - Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
S. De Rosa, C. Spaccarotella, C. Basso, M. Calabrò, Antonio Curcio, P. Filardi, M. Mancone, G. Mercuro, S. Muscoli, S. Nodari, R. Pedrinelli, G. Sinagra, C. Indolfi, Filippo Francesco Antonio Francesco Paola Leonardo Martina Angelini Barillà Bartorelli Benedetto Bernabò Bolo, F. Angelini, F. Barilla', A. Bartorelli, F. Benedetto, P. Bernabò, L. Bolognese, Martina Briani, L. Cacciavillani, A. Calabrese, P. Calabrò, L. Caliendo, L. Calo, G. Casella, G. Casu, C. Cavallini, Q. Ciampi, M. Ciccone, Michele Comito, E. Corrada, F. Crea, A. D'Andrea, M. D’Urbano, R. De Caterina, G. D. de Ferrari, R. De Ponti, Alessio Della Mattia, C. di Mario, Luca Donnazzan, G. Esposito, F. Fedele, A. Ferraro, Gennaro Galasso, N. Galié, M. Gnecchi, P. Golino, B. Golia, P. Guarini, C. Indolfi, S. Leonardi, N. Locuratolo, F. Luzza, V. Manganiello, Maria Francesca Marchetti, G. Marenzi, A. Margonato, L. Meloni, M. Metra, M. Milo, A. Mongiardo, L. Monzo, C. Morisco, S. Nodari, G. Novo, Stefano Pancaldi, M. Parollo, G. Paternò, G. Patti, S. Priori, A. Ravera, Antonio Giuseppe Rebuzzi, M. Rossi, M. Scherillo, F. Semprini, M. Senni, G. Sibilio, G. Sinagra, Massimo Siviglia, C. Tamburino, G. Tortorici, F. Versace, B. Villari, M. Volpe
European Heart Journal, 2020 - An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions
Nicola Cosentino, Emilio Assanelli, Luca Merlino, Mario Mazza, Antonio L. Bartorelli, Giancarlo Marenzi
Canadian Journal of Cardiology, 2020 - Impact of glomerular filtration rate on the incidence and prognosis of new-onset atrial fibrillation in acute myocardial infarction
Nicola Cosentino, Marco Ballarotto, Jeness Campodonico, Valentina Milazzo, Alice Bonomi, Simonetta Genovesi, Marco Moltrasio, Monica De Metrio, Mara Rubino, Fabrizio Veglia, Emilio Assanelli, Ivana Marana, Marco Grazi, Gianfranco Lauri, Antonio L. Bartorelli, Giancarlo Marenzi
Journal of Clinical Medicine, 2020 - Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Nicola Cosentino, Jeness Campodonico, Gianluca Pontone, Marco Guglielmo, Mirella Trinei, Maria Teresa Sandri, Daniela Riggio, Andrea Baggiano, Valentina Milazzo, Marco Moltrasio, Giuseppe Muscogiuri, Alice Bonomi, Simone Barbieri, Emilio Assanelli, Gianfranco Lauri, Antonio Bartorelli, Giancarlo Marenzi
International Journal of Cardiology, 2020 - Intermittent Hemofiltration for Management of Fluid Overload and Administration of Contrast Media
Giancarlo Marenzi, Gianfranco Lauri, Emilio Assanelli
Critical Care Nephrology Second Edition, 2020 - Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology
Sonia Eligini, Nicola Cosentino, Susanna Fiorelli, Franco Fabbiocchi, Giampaolo Niccoli, Hesham Refaat, Marina Camera, Giuseppe Calligaris, Stefano De Martini, Alice Bonomi, Fabrizio Veglia, Francesco Fracassi, Filippo Crea, Giancarlo Marenzi, Elena Tremoli
Scientific Reports, 2019 - High-sensitivity C-reactive protein and acute kidney injury in patients with acute myocardial infarction: A prospective observational study
Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Alice Bonomi, Claudia Lucci, Valentina Milazzo, Marco Moltrasio, Maria Luisa Biondi, Daniela Riggio, Fabrizio Veglia, Roberto Ceriani, Katia Celentano, Monica De Metrio, Mara Rubino, Antonio L. Bartorelli, Giancarlo Marenzi
Journal of Clinical Medicine, 2019 - Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk
José P. Werba, Lorenzo M. Vigo, Fabrizio Veglia, Giancarlo Marenzi, Elena Tremoli, Damiano Baldassarre
Clinical Pharmacology and Therapeutics, 2019 - 12(S)-Hydroxyeicosatetraenoic acid downregulates monocyte-derived macrophage efferocytosis: New insights in atherosclerosis
Chiara Maria Manega, Susanna Fiorelli, Benedetta Porro, Linda Turnu, Viviana Cavalca, Alice Bonomi, Nicola Cosentino, Alessandro Di Minno, Giancarlo Marenzi, Elena Tremoli, Sonia Eligini
Pharmacological Research, 2019 - Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With STEMI: A Cardiac Magnetic Resonance Study
Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini, Saima Mushtaq, Edoardo Conte, Nicola Cosentino, Mark G. Rabbat, Giancarlo Marenzi, Antonio L. Bartorelli, Mauro Pepi, Elena Tremoli, Cristina Banfi
Jacc Cardiovascular Imaging, 2019 - Activation of Nrf2/HO-1 pathway and human atherosclerotic plaque vulnerability: An in vitro and in vivo study
Susanna Fiorelli, Benedetta Porro, Nicola Cosentino, Alessandro Di Minno, Chiara Maria Manega, et al.
Cells, 2019 - Treatment of refractory vasospastic angina complicated by acute pulmonary oedema with levosimendan: A case report
Marco Moltrasio, Nicola Cosentino, Edoardo Conte, Jeness Campodonico, Giancarlo Marenzi
European Heart Journal Case Reports, 2019 - A new score based on the PEGASUS-TIMI 54 criteria for risk stratification of patients with acute myocardial infarction
Nicola Cosentino, Jeness Campodonico, Pompilio Faggiano, Monica De Metrio, Mara Rubino, Valentina Milazzo, Marco Sbolli, Carlotta Perego, Martino Provini, Alice Bonomi, Fabrizio Veglia, Antonio L. Bartorelli, Giancarlo Marenzi
International Journal of Cardiology, 2019 - Acute kidney injury: A common prognostic condition for different pathogenetic triggers?
Daniela Cardinale, Nicola Cosentino, Giancarlo Marenzi
Journal of Thoracic Disease, 2019 - High-volume hydration for the prevention of acute kidney injury after cardiac surgery
Daniela Cardinale, Nicola Cosentino, Giancarlo Marenzi, Carlo M. Cipolla
Journal of Thoracic Disease, 2019 - Extended dual antiplatelet therapy after acute myocardial infarction. Current evidence and future perspectives
Nicola Cosentino, Jeness Campodonico, Valentina Milazzo, Katia Celentano, Marco Moltrasio, Pompilio Faggiano, Giancarlo Marenzi
Monaldi Archives for Chest Disease, 2019 - Reduced cardio-renal function accounts for most of the in-hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Giancarlo Marenzi, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Monica De Metrio, Maurizio Rondinelli, Stefano Cornara, Alberto Somaschini, Rita Camporotondo, Andrea Demarchi, Valentina Milazzo, Marco Moltrasio, Mara Rubino, Ivana Marana, Marco Grazi, Gianfranco Lauri, Alice Bonomi, Fabrizio Veglia, Gaetano M. De Ferrari, Antonio L. Bartorelli
Diabetes Care, 2019 - Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease
Tobias Breidthardt, Cedric Jaeger, Andreas Christ, Theresia Klima, Tamina Mosimann, Raphael Twerenbold, Jasper Boeddinghaus, Thomas Nestelberger, Patrick Badertscher, Joachim Struck, Andreas Bergmann, Oliver Hartmann, Stefan Kalbermatter, Giancarlo Marenzi, Christian Mueller
European Journal of Clinical Investigation, 2018 - Acute kidney injury after lung cancer surgery: Incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide
Daniela Cardinale, Nicola Cosentino, Marco Moltrasio, Maria Teresa Sandri, Francesco Petrella, Alessandro Colombo, Giulia Bacchiani, Adele Tessitore, Alice Bonomi, Fabrizio Veglia, Michela Salvatici, Carlo M. Cipolla, Giancarlo Marenzi, Lorenzo Spaggiari
Lung Cancer, 2018 - Impact of Chronic Antiplatelet Therapy on Infarct Size and Bleeding in Patients With Acute Myocardial Infarction
Jeness Campodonico, Nicola Cosentino, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana, Marco Moltrasio, Marco Grazi, Gianfranco Lauri, Alice Bonomi, Fabrizio Veglia, Elisa Chiorino, Emilio Assanelli, Antonio L. Bartorelli, Giancarlo Marenzi
Journal of Cardiovascular Pharmacology and Therapeutics, 2018 - Acute kidney injury in diabetic patients with acute myocardial infarction: Role of acute and chronic glycemia
Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri, Alice Bonomi, Simone Barbieri, Emilio Assanelli, Alessia Dalla Cia, Roberto Manfrini, Roberto Ceriani, Antonio Bartorelli
Journal of the American Heart Association, 2018 - Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: A prospective study
Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Milena Cecere, et al.
Diabetes Care, 2018 - QT-interval evaluation in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction for prediction of myocardial salvage index
Andrea Igoren Guaricci, Patrizia Carità, Valentina Lorenzoni, GraziaPia Casavecchia, Mark Rabbat, et al.
Plos One, 2018 - Extracorporeal ultrafiltration for acute heart failure: Patient selection and perspectives
Valentina Milazzo, Nicola Cosentino, Giancarlo Marenzi
Vascular Health and Risk Management, 2017 - Prognostic stratification of patients with ST-segment-elevation myocardial infarction (PROSPECT): A cardiac magnetic resonance study
Gianluca Pontone, Andrea I. Guaricci, Daniele Andreini, Giovanni Ferro, Marco Guglielmo, Andrea Baggiano, Laura Fusini, Giuseppe Muscogiuri, Valentina Lorenzoni, Saima Mushtaq, Edoardo Conte, Andrea Annoni, Alberto Formenti, Maria Elisabetta Mancini, Patrizia Carità, Massimo Verdecchia, Silvia Pica, Fabio Fazzari, Nicola Cosentino, Giancarlo Marenzi, Mark G. Rabbat, Piergiuseppe Agostoni, Antonio L. Bartorelli, Mauro Pepi, Pier Giorgio Masci
Circulation Cardiovascular Imaging, 2017 - A multicenter feasibility study on ultrafiltration via a single peripheral venous access in acute heart failure with overt fluid overload
Marco Morpurgo, Mario Pasqualini, Maria Cristiana Brunazzi, Gabriele Vianello, Roberto Valle, et al.
International Journal of Cardiology, 2017 - Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry
Leonardo De Luca, Giuseppe Musumeci, Sergio Leonardi, Lucio Gonzini, Claudio Cavallini, et al.
Journal of Cardiovascular Medicine, 2017 - Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research
Maria Rosa Costanzo, Claudio Ronco, William T. Abraham, Piergiuseppe Agostoni, Jonathan Barasch, et al.
Journal of the American College of Cardiology, 2017 - Renal replacement therapy in patients with acute myocardial infarction: Rate of use, clinical predictors and relationship with in-hospital mortality
Giancarlo Marenzi, Nicola Cosentino, Andrea Marinetti, Antonio M. Leone, Valentina Milazzo, et al.
International Journal of Cardiology, 2017 - High Urine Output With Matched Hydration for CI-AKI Prevention: “Salus Per Aquam” (Health Through Water)
Antonio L. Bartorelli, Giancarlo Marenzi
Jacc Cardiovascular Interventions, 2017 - Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone, Efthymios N. Deliargyris, Ph. Gabriel Steg, et al.
Journal of the American College of Cardiology, 2017 - Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction
Giancarlo Marenzi, Nicola Cosentino, Jasper Boeddinghaus, Mirella Trinei, Marco Giorgio, et al.
Circulation Research, 2016 - The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
Markku S. Nieminen, Michael Buerke, Alain Cohen-Solál, Susana Costa, István Édes, et al.
International Journal of Cardiology, 2016 - Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Giancarlo Marenzi, Nicola Cosentino, Marco Moltrasio, Mara Rubino, Gabriele Crimi, et al.
Journal of the American Heart Association, 2016 - B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
Gianfranco Lauri, Chiara Rossi, Mara Rubino, Nicola Cosentino, Valentina Milazzo, et al.
International Journal of Cardiology, 2016 - Contrast-induced nephropathy in patients undergoing primary angioplasty: Prognostic implications, prevention, and management
Mechanical Reperfusion for Stemi from Randomized Trials to Clinical Practice, 2016 - Brain natriuretic peptide in acute myocardial infarction: A marker of cardio-renal interaction
Marco Moltrasio, Nicola Cosentino, Monica De Metrio, Mara Rubino, Angelo Cabiati, et al.
Journal of Cardiovascular Medicine, 2016 - The AVOID-HF Trial: Points to Consider
Giancarlo Marenzi, Amir Kazory
Jacc Heart Failure, 2016 - Peri-angiography hemofiltration to reduce mortality
Giancarlo Marenzi, Nicola Cosentino, Antonio L. Bartorelli
Reducing Mortality in Acute Kidney Injury, 2016 - Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
Giancarlo Marenzi, Nicola Cosentino, Sarah Cortinovis, Valentina Milazzo, Mara Rubino, et al.
American Journal of Cardiology, 2015 - Acute kidney injury in patients with acute coronary syndromes
Giancarlo Marenzi, Nicola Cosentino, Antonio L Bartorelli
Heart, 2015 - How to balance risks and benefits in the management of CKD patients with coronary artery disease
Giancarlo Marenzi, Nicola Cosentino, Carlo Guastoni
Journal of Nephrology, 2015 - Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study
Leonardo De Luca, Sergio Leonardi, Ignazio Maria Smecca, Dario Formigli, Donata Lucci, et al.
European Heart Journal Cardiovascular Pharmacotherapy, 2015 - Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes
Monica De Metrio, Valentina Milazzo, Mara Rubino, Angelo Cabiati, Marco Moltrasio, et al.
Medicine United States, 2015 - Continuous Ultrafiltration in Acute Decompensated Heart Failure: Current Issues and Future Directions
Giancarlo Marenzi, Marco Morpurgo, Piergiuseppe Agostoni
American Journal of Cardiovascular Drugs, 2015 - A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes
Giancarlo Marenzi, Nicola Cosentino, José P. Werba, Calogero C. Tedesco, Fabrizio Veglia, Antonio L. Bartorelli
International Journal of Cardiology, 2015 - Fenoldopam in patients with postoperative acute renal failure
Giornale Italiano Di Cardiologia, 2015 - Ultrafiltration for congestive heart failure: The past and the present
Giancarlo Marenzi, Amir Kazory, Piergiuseppe Agostoni
Current Opinion in Cardiology, 2015 - Prognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromes
Giancarlo Marenzi, Angelo Cabiati, Nicola Cosentino, Emilio Assanelli, Valentina Milazzo, et al.
American Heart Journal, 2015 - Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries
Giornale Italiano Di Nefrologia Organo Ufficiale Della Societa Italiana Di Nefrologia, 2015 - Post-procedural hemodiafiltration in acute coronary syndrome patients with associated renal and cardiac dysfunction undergoing urgent and emergency coronary angiography
Giancarlo Marenzi, Gianfranco Mazzotta, Francesco Londrino, Roberto Gistri, Marco Moltrasio, et al.
Catheterization and Cardiovascular Interventions, 2015 - Continuous ultrafiltration for congestive heart failure: the CUORE trial
Journal of Cardiac Failure, 2014 - B-Type Natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes
Marco Moltrasio, Angelo Cabiati, Valentina Milazzo, Mara Rubino, Monica De Metrio, et al.
Critical Care Medicine, 2014 - Extracorporeal ultrafiltration for heart failure: Focus on organ cross talk and clinical trials
Ivana Marana, Giancarlo Marenzi, Amir Kazory
Nephrologie Et Therapeutique, 2014 - The POSEIDON study
Giornale Italiano Di Cardiologia, 2014 - Continuous ultrafiltration for congestive heart failure: The CUORE trial
Giancarlo Marenzi, Manuela Muratori, Eugenio R. Cosentino, Elisa R. Rinaldi, Valeria Donghi, et al.
Journal of Cardiac Failure, 2014 - The PRATO-ACS study
Giancarlo Marenzi, Carlo Briguori
Giornale Italiano Di Cardiologia, 2013 - Diagnostic potential of plasmatic microRNA signatures in stable and unstable angina
Yuri D'Alessandra, Maria Cristina Carena, Liana Spazzafumo, Federico Martinelli, Beatrice Bassetti, et al.
Plos One, 2013 - Questing for circadian dependence in ST-segment-elevation acute myocardial infarction: A multicentric and multiethnic study
Enrico Ammirati, Nicole Cristell, Domenico Cianflone, Anna-Chiara Vermi, Giancarlo Marenzi, et al.
Circulation Research, 2013 - The CARRESS study
Giornale Italiano Di Cardiologia, 2013 - Ultrafiltration in refractory heart failure
Giancarlo Marenzi, Nadia Aspromonte
Journal of the American College of Cardiology, 2013 - Incidence and relevance of acute kidney injury in patients hospitalized with acute coronary syndromes
Giancarlo Marenzi, Angelo Cabiati, Silvio V. Bertoli, Emilio Assanelli, Ivana Marana, et al.
American Journal of Cardiology, 2013 - Circulating Levels of Dimethylarginines, Chronic Kidney Disease and Long-Term Clinical Outcome in Non-ST-Elevation Myocardial Infarction
Viviana Cavalca, Fabrizio Veglia, Isabella Squellerio, Monica De Metrio, Mara Rubino, et al.
Plos One, 2012 - Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6-interleukin-10+ cytokine patterns in st-elevation acute myocardial infarction
Enrico Ammirati, Carlo V. Cannistraci, Nicole A. Cristell, Viviana Vecchio, Alessio G. Palini, et al.
Circulation Research, 2012 - Contrast-induced nephropathy
Giancarlo Marenzi, Angelo Cabiati, Valentina Milazzo, Mara Rubino
Internal and Emergency Medicine, 2012 - Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: A post-hoc analysis of a multicenter randomized controlled trial
Michael Osthoff, Vanja Piezzi, Theresia Klima, Andreas Christ, Ivana Marana, et al.
BMC Nephrology, 2012 - Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction
Monica De Metrio, Valentina Milazzo, Giancarlo Marenzi
Clinical Research in Cardiology, 2012 - Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: A randomized controlled trial
T. Klima, A. Christ, I. Marana, S. Kalbermatter, H. Uthoff, et al.
European Heart Journal, 2012 - An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes
Norma Maugeri, Patrizia Rovere-Querini, Virgilio Evangelista, Cosmo Godino, Monica Demetrio, et al.
Plos One, 2012 - Vorapaxar in the secondary prevention of atherothrombotic events
David A. Morrow, Eugene Braunwald, Marc P. Bonaca, Sebastian F. Ameriso, Anthony J. Dalby, et al.
New England Journal of Medicine, 2012 - Reply
Giancarlo Marenzi, Cristina Ferrari, Antonio L. Bartorelli
Jacc Cardiovascular Interventions, 2012 - Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: The case of copeptin
Giuseppe Lippi, Mario Plebani, Salvatore Di Somma, Valter Monzani, Marco Tubaro, et al.
Clinical Chemistry and Laboratory Medicine, 2012 - Renal replacement Therapies for prevention of radiocontrast-induced nephropathy: A systematic review
Dinna N. Cruz, Ching Yan Goh, Giancarlo Marenzi, Valentina Corradi, Claudio Ronco, et al.
American Journal of Medicine, 2012 - Prevention of contrast nephropathy by furosemide with matched hydration: The MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial
Giancarlo Marenzi, Cristina Ferrari, Ivana Marana, Emilio Assanelli, Monica De Metrio, et al.
Jacc Cardiovascular Interventions, 2012 - High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: A multiethnic case-control study
Nicole Cristell, Domenico Cianflone, Alessandro Durante, Enrico Ammirati, Diego Vanuzzo, et al.
Journal of the American College of Cardiology, 2011 - N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery
Erminio Sisillo, Giancarlo Marenzi
Journal of Clinical Pharmacology, 2011 - Kinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgery
Piergiuseppe Agostoni, Cristina Banfi, Damiano Magrì, Carlo Vignati, Elisabetta Doria, et al.
Respiratory Physiology and Neurobiology, 2011 - Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome
Gualtiero Colombo, Karl Gertow, Giancarlo Marenzi, Marta Brambilla, Monica De Metrio, et al.
Thrombosis Research, 2011 - Author's reply to Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
Giancarlo Marenzi, Monica De Metrio, Antonio L. Bartorelli
American Heart Journal, 2011 - Evaluation of the sensitivity of two highly sensitive troponin assays for early detection of non ST-elevation myocardial infarction (NSTEMI)
Biochimica Clinica, 2011 - Surfactant protein B and RAGE increases in the plasma during cardiopulmonary bypass: A pilot study
P. Agostoni, C. Banfi, M. Brioschi, D. Magrì, S. Sciomer, et al.
European Respiratory Journal, 2011 - Ultrafiltration for the management of fluid overload: Only for refractory end-stage heart failure syndrome?
Mediterranean Journal of Pacing and Electrophysiology, 2011 - Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention
Giancarlo Marenzi, Monica De Metrio, Mara Rubino, Gianfranco Lauri, Annalisa Cavallero, et al.
American Heart Journal, 2010 - Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction
Giancarlo Marenzi, Marco Giorgio, Mirella Trinei, Marco Moltrasio, Paolo Ravagnani, et al.
American Journal of Cardiology, 2010 - Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
Yuri D'Alessandra, Paolo Devanna, Federica Limana, Stefania Straino, Anna Di Carlo, et al.
European Heart Journal, 2010 - Circulating CD4+CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis
Enrico Ammirati, Domenico Cianflone, Michela Banfi, Viviana Vecchio, Alessio Palini, Monica De Metrio, Giancarlo Marenzi, Claudio Panciroli, Gabriele Tumminello, Angelo Anzuini, Altin Palloshi, Liliana Grigore, Katia Garlaschelli, Simona Tramontana, Davide Tavano, Flavio Airoldi, Angelo A. Manfredi, Alberico Luigi Catapano, Giuseppe Danilo Norata
Arteriosclerosis Thrombosis and Vascular Biology, 2010 - Extracorporeal fluid removal in heart failure patients
Fluid Overload, 2010 - Proteome of platelets in patients with coronary artery disease
Cristina Banfi, Maura Brioschi, Giancarlo Marenzi, Monica De Metrio, Marina Camera, et al.
Experimental Hematology, 2010 - Extracorporeal fluid removal in heart failure patients
Maria Rosa Costanzo, Piergiuseppe Agostoni, Giancarlo Marenzi
Contributions to Nephrology, 2010 - Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission
Giancarlo Marenzi, Emilio Assanelli, Jeness Campodonico, Monica De Metrio, Gianfranco Lauri, et al.
Critical Care Medicine, 2010 - Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients
Corrado Carbucicchio, Paolo Della Bella, Gaetano Fassini, Nicola Trevisi, Stefania Riva, et al.
Herz, 2009 - Radiocontrast-Induced Nephropathy
Giancarlo Marenzi, Antonio L. Bartorelli
Pharmacology in the Catheterization Laboratory, 2009 - Renal-Protective Agents
Giancarlo Marenzi, Antonio L. Bartorelli
Pharmacology in the Catheterization Laboratory, 2009 - High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy
Hariprasad Trivedi, Sumanth Daram, Aniko Szabo, Antonio L. Bartorelli, Giancarlo Marenzi
American Journal of Medicine, 2009 - Use of levosimendan for treatment of cardiogenic shock associated with electrical storm
Marco Grazi, Gianfranco Lauri, Corrado Carbucicchio, Giancarlo Marenzi
Annals of Internal Medicine, 2009 - Glutathione, vitamin e and oxidative stress in coronary artery disease: Relevance of age and gender
V. Cavalca, F. Veglia, I. Squellerio, G. Marenzi, F. Minardi, et al.
European Journal of Clinical Investigation, 2009 - Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality
Giancarlo Marenzi, Emilio Assanelli, Jeness Campodonico, Gianfranco Lauri, Ivana Marana, et al.
Annals of Internal Medicine, 2009 - Prevention of contrast-induced nephropathy and management of high-risk patients
Giornale Italiano Di Cardiologia, 2009 - Intermittent Hemofiltration for Management of Fluid Overload and Administration of Contrast Media
Giancarlo Marenzi, Gianfranco Lauri, Emilio Assanelli
Critical Care Nephrology Second Edition, 2009 - Tissue factor in patients with acute coronary syndromes: Expression in platelets, leukocytes, and platelet-leukocyte aggregates
Marta Brambilla, Marina Camera, Deborah Colnago, Giancarlo Marenzi, Monica De Metrio, et al.
Arteriosclerosis Thrombosis and Vascular Biology, 2008 - Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography
Giancarlo Marenzi
Nature Clinical Practice Nephrology, 2008 - Contrast-induced nephropathy
ANTONIO L. BARTORELLI, GIANCARLO MARENZI
Journal of Interventional Cardiology, 2008 - Intermittent Hemofiltration for Management of Fluid Overload and Administration of Contrast Media
Giancarlo Marenzi, Gianfranco Lauri, Emilio Assanelli
Critical Care Nephrology Second Edition, 2008 - Contrast medium dose-to-GFR ratio: A measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention
U. Nyman, J. Björk, P. Aspelin, G. Marenzi
Acta Radiologica, 2008 - N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial
Erminio Sisillo, Roberto Ceriani, Franco Bortone, Glauco Juliano, Luca Salvi, et al.
Critical Care Medicine, 2008 - Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial [2]
G. Marenzi, A. L. Bartorelli
European Heart Journal, 2007 - The Reply:
Giancarlo Marenzi, Antonio L. Bartorelli
American Journal of Medicine, 2007 - Management of renal complications during primary angioplasty
Recenti Progressi in Medicina, 2007 - Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty
Giancarlo Marenzi, Marco Moltrasio, Emilio Assanelli, Gianfranco Lauri, Ivana Marana, et al.
American Heart Journal, 2007 - ¿Previene el tratamiento con N-acetil-cisteína (NAC) la nefropatía asociada a contrastes yodados en la angioplastia primaria por síndrome coronario agudo? Comentarios
Nefrologia, 2007 - ¿Es más eficaz la hemofiltración (HF) pre y post que la hidratación intravenosa con suero salino en la prevención el nefrotoxicidad por contrastres yodados en una población de alto riesgo? Comentarios
Nefrologia, 2007 - Gas diffusion and alveolar-capillary unit in chronic heart failure
P. Agostoni, M. Bussotti, G. Cattadori, E. Margutti, M. Contini, et al.
European Heart Journal, 2006 - The authors reply [9]
New England Journal of Medicine, 2006 - N-acetylcysteine and contrast-induced nephropathy in primary angioplasty
Giancarlo Marenzi, Emilio Assanelli, Ivana Marana, Gianfranco Lauri, Jeness Campodonico, et al.
New England Journal of Medicine, 2006 - Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction
Daniela Trabattoni, Antonio L. Bartorelli, Franco Fabbiocchi, Piero Montorsi, Paolo Ravagnani, et al.
Catheterization and Cardiovascular Interventions, 2006 - Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients
Giancarlo Marenzi, Gianfranco Lauri, Jeness Campodonico, Ivana Marana, Emilio Assanelli, et al.
American Journal of Medicine, 2006 - Contrast-induced nephropathy: Pharmacological prophylaxis
C. Briguori, G. Marenzi
Kidney International, 2006 - Management of acute coronary syndromes in patients with renal insufficiency
Giancarlo Marenzi, Emilio Assanelli, Antonio Bartorelli
Current Cardiology Reviews, 2006 - [Extracorporeal treatment in patients with heart failure: pathophysiology, indications and results].
Giornale Italiano Di Nefrologia Organo Ufficiale Della Societa Italiana Di Nefrologia, 2006 - Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: A new tool for heart failure evaluation [1]
Piergiuseppe Agostoni, Gaia Cattadori, Anna Apostolo, Mauro Contini, Pietro Palermo, et al.
Journal of the American College of Cardiology, 2005 - Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
Giancarlo Marenzi
Nature Clinical Practice Cardiovascular Medicine, 2005 - Recent advances in the prevention of radiocontrast-induced nephropathy
Current Opinion in Critical Care, 2004 - Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
Giancarlo Marenzi, Gianfranco Lauri, Emilio Assanelli, Jeness Campodonico, Monica De Metrio, et al.
Journal of the American College of Cardiology, 2004 - Hemofiltration in the prevention of radiocontrast agent induced nephropathy
Minerva Anestesiologica, 2004 - Hemofiltration and the Prevention of Radiocontrast-Agent-Induced Nephropathy [1] (multiple letters)
Ajit Singh Kashyap, Kuldip Parkash Anand, Surekha Kashyap
New England Journal of Medicine, 2004 - Hemofiltration in heart failure
G. Marenzi, P. Agostoni
International Journal of Artificial Organs, 2004 - Circadian distribution of acute myocardial infarction by anatomic location and coronary artery involvement
Paolo Moruzzi, Giancarlo Marenzi, Sergio Callegari, Mauro Contini
American Journal of Medicine, 2004 - The prevention of radiocontrast-agent-induced nephropathy by hemofiltration
Giancarlo Marenzi, Ivana Marana, Gianfranco Lauri, Emilio Assanelli, Marco Grazi, et al.
New England Journal of Medicine, 2003 - Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions
GianCarlo Marenzi, Antonio L. Bartorelli, Gianfranco Lauri, Emilio Assanelli, Marco Grazi, et al.
Catheterization and Cardiovascular Interventions, 2003 - Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure
GianCarlo Marenzi, Gianfranco Lauri, Emilio Assanelli, Marco Grazi, Jeness Campodonico, et al.
European Journal of Heart Failure, 2002 - Pulmonary hemodynamic and tidal volume changes during exercise in heart failure
Italian Heart Journal, 2002 - Sustained benefit from Ultrafiltration in moderate congestive heart failure
PierGiuseppe Agostoni, GianCarlo Marenzi
Cardiology, 2001 - Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure
GianCarlo Marenzi, Gianfranco Lauri, Marco Grazi, Emilio Assanelli, Jeness Campodonico, et al.
Journal of the American College of Cardiology, 2001 - Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation
Francesco Casilli, Emilio Assanelli, Marco Grazi, Giancarlo Marenzi, Maurizio Guazzi, et al.
Thrombosis and Haemostasis, 2001 - Cardiac and renal dysfunction in chronic heart failure: Relation to neurohumoral activation and prognosis
Giancarlo Marenzi, Gianfranco Lauri, Marco Guazzi, Emilio Assanelli, Marco Grazi, et al.
American Journal of the Medical Sciences, 2001 - Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure
PierGiuseppe Agostoni, Marco Guazzi, Maurizio Bussotti, Marco Grazi, Pietro Palermo, et al.
Journal of the American College of Cardiology, 2000 - Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure
Piergiuseppe Agostoni, Gaia Cattadori, Marco Guazzi, Maurizio Bussotti, Cristina Conca, et al.
American Journal of Medicine, 2000 - The noradrenaline plasma concentration and its gradient across the lung
Marenzi, Agostoni, Guazzi, Lauri, Assanelli, et al.
European Journal of Clinical Investigation, 2000 - Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure.
PierGiuseppe Agostoni, Gaia Cattadori, Marco Guazzi, Pietro Palermo, Maurizio Bussotti, et al.
American Heart Journal, 2000 - Non-invasive measurement of stroke volume during exercise in heart failure patients
Pier Giuseppe AGOSTONI, Karlman WASSERMAN, Giovanni B. PEREGO, Marco GUAZZI, Gaia CATTADORI, et al.
Clinical Science, 2000 - The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease
Mauro Pepi, PierGiuseppe Agostoni, GianCarlo Marenzi, Elisabetta Doria, Marco Guazzi, et al.
European Journal of Heart Failure, 1999 - Exercise-induced hemoconcentration in heart failure due to dilated cardiomyopathy
Piergiuseppe Agostoni, Karlman Wasserman, Marco Guazzi, Gaia Cattadori, Pietro Palermo, et al.
American Journal of Cardiology, 1999 - Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction
M GUAZZI, G MELZI, G MARENZI, P AGOSTONI
Clinical Pharmacology and Therapeutics, 1999 - Platelet activity in the early stage of acute myocardial infarction: Relation to time of presentation, treatment with either tissue plasminogen activator or streptokinase and cyclooxygenase inhibition
Alessandro Salvioni, Giovanni B. Perego, Giancarlo Marenzi, Stefano Galli, Emilio Assanelli, et al.
Journal of Thrombosis and Thrombolysis, 1998 - Effects of cardiomegaly on the anatomical and functional state of the lung in chronic heart failure
Cardiologia Rome Italy, 1998 - Intra- and extravascular volumes in congestive heart failure and their redistribution following extracorporeal ultrafiltration
Cardiologia Rome Italy, 1998 - Platelet activation in the early phases of acute myocardial infarction
Cardiologia Rome Italy, 1998 - Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty
Alessandro Salvioni, Stefano Galli, Giancarlo Marenzi, Gianfranco Lauri, Giovanni B. Perego, et al.
American Heart Journal, 1998 - Oxygen transport to muscle during exercise in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy
PierGiuseppe Agostoni, Karlman Wasserman, Giovanni Battista Perego, Gian Carlo Marenzi, Marco Guazzi, et al.
American Journal of Cardiology, 1997 - Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin
Marco Guazzi, Giancarlo Marenzi, Marina Alimento, Mauro Contini, Piergiuseppe Agostoni
Circulation, 1997 - The duration of the benefits of ultrafiltration in patients with moderate heart failure
Cardiologia Rome Italy, 1997 - The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure
Cardiologia Rome Italy, 1997 - Mechanisms facilitating oxygen delivery during exercise in patients with chronic heart failure
Cardiologia Rome Italy, 1997 - Influence of ACE inhibition on fluid metabolism in chronic heart failure and its pathophysiologic relevance
Piergiuseppe Agostoni, Giancarlo Marenzi, Marco Guazzi, Maurizio D. Guazzi
Journal of Cardiovascular Pharmacology and Therapeutics, 1996 - Extracorporeal ultrafiltration
Cardiologia Rome Italy, 1996 - Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate
A. Salvioni, G. B. Perego, G. Marenzi, G. Lauri, F. Giraldi, et al.
European Heart Journal, 1996 - Contribution of Po2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure
G. B. Perego, G. C. Marenzi, M. Guazzi, P. Sganzerla, E. Assanelli, et al.
Journal of Applied Physiology, 1996 - Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure
Pier Giuseppe Agostoni, Gian Carlo Marenzi, Paolo Sganzerla, Emilio Assanelli, Marco Guazzi, et al.
American Journal of Cardiology, 1995 - Ultrafiltration in moderate heart failure: Exercise oxygen uptake as a predictor of the clinical benefits
Gian Carlo Marenzi, Gianfranco Lauri, Marco Guazzi, Giovanni Battista Perego, Pier Giuseppe Agostoni
Chest, 1995 - Measurement of dead space/tidal volume ratio during exercise in patients with heart failure
Cardiologia Rome Italy, 1995 - Evaluation of the dead space/tidal volume ratio in patients with chronic congestive heart failure
Marco Guazzi, Giancarlo Marenzi, Emilio Assanelli, Giovanni B. Perego, Gaia Cattadori, et al.
Journal of Cardiac Failure, 1995 - Inhibition of the neurohumoral axis after intravascular fluid depletion in congestive heart failure with water retention: mechanisms of the perpetuation of the syndrome
Cardiologia Rome Italy, 1995 - Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase
European Heart Journal, 1994 - Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result
Cardiologia Rome Italy, 1994 - β-Thromboglobulin plasma levels in the first week after myocardial infarction: Influence of thrombolytic therapy
Alessandro Salvioni, Giancarlo Marenzi, Gianfranco Lauri, Francesco Giraldi, Giovanni B. Perego, et al.
American Heart Journal, 1994 - Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result
Piergiuseppe Agostoni, Giancarlo Marenzi, Gianfranco Lauri, Giovanbattista Perego, Maurizio Schianni, et al.
American Journal of Medicine, 1994 - Apparent-paradox of neurohumoral axis inhibition after body fluid volume deletion in patients with chronic congestive heart failure and water retention
British Heart Journal, 1994 - Moderate cardiac failure: oxygen consumption during exercise predicts ultrafiltration results
Cardiologia Rome Italy, 1994 - The factors that regulate water-salt metabolism in congestive heart failure
Cardiologia Rome Italy, 1993 - Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: Pathophysiological correlates
M Pepi, G C Marenzi, P G Agostoni, E Doria, P Barbier, et al.
British Heart Journal, 1993 - Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: Effects of extracorporeal ultrafiltration
Giancarlo Marenzi, Sergio Grazi, Francesco Giraldi, Gianfranco Lauri, Giovanbattista Perego, et al.
American Journal of Medicine, 1993 - Changes in the physical characteristics of the lung can account for the improvement observed after ultrafiltration in patients with moderate heart failure
Cardiologia Rome Italy, 1993 - Isolated ultrafiltration in moderate congestive heart failure
Pier Giuseppe Agostoni, Gian Carlo Marenzi, Mauro Pepi, Elisabetta Doria, Alessandro Salvioni, et al.
Journal of the American College of Cardiology, 1993 - Intranodal versus perinodal tachycardia: Possible distinguishing criteria
New Trends in Arrhythmias, 1992 - Interrelation of plasma volume, fluid metabolism and neurohormonal activation after ultrafiltration in congestive heart failure
Cardiologia Rome Italy, 1992 - Usefulness of excitable gap and pattern of resetting in atrial flutter for determining reentry circuit location
Paolo Della Bella, Giancarlo Marenzi, Claudio Tondo, Daniela Cardinale, Francesco Giraldi, et al.
American Journal of Cardiology, 1991 - Polymorphous ventricular tachycardia as undesirable effect of the association of quinidine treatment with hysteresis ventricular inhibited pacing
European Heart Journal, 1990 - Atrial flutter termination by overdrive pacing: Relation to changes of excitable gap induced by different antiarrhythmic drugs
New Trends in Arrhythmias, 1990 - Neurohumoral changes induced by hemofiltration in congestive heart failure: physiopathological inferences
Cardiologia Rome Italy, 1990 - Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing
Paolo Della Bella, Giancarlo Marenzi, Claudio Tondo, Flavio Doni, Gianfranco Lauri, et al.
American Journal of Cardiology, 1989 - Pretreatment with disopyramide is effective in patients with overdrive atrial pacing for atrial flutter
Cardiologia, 1989 - Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing
Paolo Della Bella, Claudio Tondo, Giancarlo Marenzi, Carlo M. Cipolla, Flavio Doni, et al.
American Journal of Cardiology, 1988 - Hemofiltration as an acute remedy in intractable cardiac decompensation. Guidelines for correct application
Cardiologia, 1987 - Acute treatment of refractory congestive heart failure using hemofiltration
Cardiologia, 1987
